FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson/Atrophy Program
March 08, 2023 at 11:41 AM EST
The FDA lifted the full Clinical Hold onInhibikase Therapeutics Inc's(NASDAQ: IKT) IkT-148009, the company's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.